Why some of Biden's top doctors are wearing masks in "low" COVID areas
The CDC director said she has been "masking more" because of upcoming events she did not want to miss.
Alexander Tin is a digital reporter for CBS News based in the Washington, D.C. bureau. He covers the Biden administration's public health agencies, including the federal response to infectious disease outbreaks like COVID-19. Previously, he was a campaign reporter for CBS News based out of Las Vegas, where he was raised. He covered presidential, Senate and House candidates for the 2020 election cycle in Arizona, California, Nevada and New Mexico. He has also worked in Washington for "Face the Nation" and in New York for the "CBS Evening News." Tin graduated from Columbia University in 2017 with a bachelor's degree in political science.
The CDC director said she has been "masking more" because of upcoming events she did not want to miss.
CDC data showed firearm homicides rose 35% during the first year of the pandemic to the highest rate since 1994.
If symptoms return, FDA says there's "no evidence" taking more Paxlovid helps.
Health and Human Services Secretary Xavier Becerra pledged to devote "far more resources towards mental health care" in wake of the pandemic's toll.
The Food and Drug Administration released a "tentative" schedule of meetings for its outside vaccine advisers in June.
The FDA has pledged to "move with all expediency" to review the company's data on a lower-dose kids' vaccine.
In the wake of the Omicron variant wave over the winter, more than half of Americans are estimated to have antibodies from a previous infection.
Federal officials say highly effective drugs have been underutilized and could help more Americans fight COVID-19.
The president's chief medical adviser criticized the "disturbing" decision by "a judge with no experience in public health."
InspectIR COVID-19 Breathalyzer test can detect infections using only a breath sample and yield results in less than three minutes.
Citing a "robust response" of antibodies against Omicron in their vaccine trials, the companies said they were planning to submit a request "in the coming days."
As prevalence of the Omicron subvariant nears 90% nationwide, officials around the world are already tracking the rise of dozens of new potential variants.
The agency recently reversed recommendations against routine surveillance of the virus in wildlife, as officials huddle to strategize over the potential threat.
BA.2's prevalence remains highest in the Northeast, where the agency estimates that the variant made up close to three-quarters of new infections.
Immunocompromised Americans are also now eligible for an extra dose, as well as all those first vaccinated with Johnson & Johnson's vaccine.